July 21, 2025 – Anthem Biosciences Ltd made its stock market debut today. The IPO was listed on both NSE and BSE at 10 AM. The company gave good returns to investors on the very first day.
Huge Interest in the IPO
- The IPO got very strong demand. It was subscribed 63.86 times.
- Big investors (QIBs) subscribed 192.8 times, small companies (NIIs) subscribed 44.7 times, and retail investors subscribed 6 times.
- The IPO was open from July 14 to July 16. Shares were allotted on July 17.
GMP (Grey Market Premium)
- In the grey market, the shares were trading at ₹169–177 above the issue price.
- This showed the listing price could be around ₹739 to ₹747.
Listing Performance
- Anthem Biosciences listed at ₹723, which is about 27% higher than the issue price.
- On NSE, the share opened at ₹723.05. On BSE, it was ₹723.10.
- During the day, the price went up to ₹746.70, a gain of another 3.3%.
What Experts Say
- Experts said this is a strong sign that investors trust the company.
- The company works in the biotech field and follows a CRDMO model. It makes special chemicals and biotech products.
- Many experts believe this company can grow a lot in the future.
- Some experts also said that if investors made good profits on day one, they can sell some shares and keep the rest.
Summary Table
| Point | Details |
|---|---|
| IPO Dates | July 14 to July 16, 2025 |
| Subscription | 63.86× (QIBs 193×, NIIs 45×, Retail 6×) |
| Listing Date | July 21, 2025 |
| Listing Price | ₹723 (~27% higher) |
| Highest Price Today | ₹746.70 (+3.3%) |
Anthem Biosciences gave a strong listing. It made good profits for early investors. With its strong business and demand, it looks like the company will perform well in the biotech sector in India and abroad.
